2nd APV Conference on “Highly Potent Drug Products in the Pharmaceutical Industry”  | KN 6764

19.03. - 20.03.2019 | Wiesloch (close to Heidelberg), Germany


Best Western Plus Palatin Kongresshotel
Ringstr. 17-19
69168 Wiesloch (close to Heidelberg)
Tel.:+49 6222 582 010
Fax:+49 6222 582 555

Kursprogramm zum Download


Summary and objectives
After the huge success of the first APV conference on highly potent drug products in 2015, this year’s
second conference on highly potent drug products will again focus on the development and manufacturing of drug products in an highly potent environment rather than the generic challenges of
highly potent drug substances as such, which are already covered widely in a range of other conferences.

In contrast to these the APV 2nd Conference on Highly Potent Drug Products in the Pharmaceutical Industry will provide participants with an inside view of the everyday challenges when having to develop, manufacture and test drug products with highly potent drug compounds. You will also have
the opportunity to have discussions with the experts on practical hurdles faced when working
with these compounds in a development or GMP environment and to solutions, which have proven
to be working in a highly potent routine.

Besides an overview on innovation in the area and the regulatory status for handling such products, the conference will focus on these practical aspects different stakeholders are facing when handling
highly potent drug products.

Furthermore the topics and discussions also highlight challenges for interfaces between the various parties involved in the manufacturing and administration of highly potent drug products. Therefore, this interdisciplinary conference is going to address the topic of highly potent drug products in a holistic approach involving not only the chemists, formulation scientists, analytical experts, quality officers and safety officers in both the development and production environment, but also the dispensing pharmacists in the hospital or community pharmacy and the handling of such products at the patient level.

Both, the invited speakers and the organizers of the conference are experts in the area and willing to share their own experience in this field of growing interest but also still unmet challenges with the participants during this unique conference. And they will openly discuss different philosophies and approaches as applied by different companies.

In addition to plenary talks from the experts in the area and round table discussions participants will also have the opportunity to see the manufacturing of highly potent drug products in “real life” when they visit the Corden Pharma Plankstadt facilities in Plankstadt, a specialist provider for the development and manufacturing of highly potent solid dosage forms.

The conference includes a visit to the Corden site where participants will see both,

  • the recently established, fully contained high potent development area for OEB 3 – OEB 5compounds suitable for small scale feasibility trials at a batch size of 10 – 500 g in a non GMP environment and
  • the latest addition to the company’s highly potent manufacturing plants; the fully contained OEB 5 plant for commercial scale manufacturing at a scale of 100 – 500 kg

An exhibition with solution providers for the development and manufacturing of highly potent drug products will also provide the opportunity to directly discuss technical and set up solutions with the providers during the conference.


Iris Ziegler

Director Development and Production
Corden Pharma Plankstadt, Germany

Karoline Bechthold Peters

Senior Strategy & Technology Leader Pharmaceutics
Novartis, Switzerland

Susanne Page

Head of Formulation Research & Development
F. Hoffmann-La Roche, Switzerland

Horst-Dieter Friedel

Head of External Affairs
Bayer Pharma AG, Product Supply Pharma - Quality Assurance Pharma and API Berlin, Germany


Induytry 1.490,00 €
Academia / Authorities 745,00 €
Student (limited places) 178,00 €
Alle Preise mehrwertsteuerfrei gemäß § 4,22 UStG



Dr. Martin Bornhöft
Tel.: +49 6131 9769-0
Fax: +49 6131 9769-69
E-Mail: apv@apv-mainz.de
www: https://www.apv-mainz.de/